Clinical Trial Update: Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]

View source ↗

Summary

Phase 3 trial results for saxagliptin in adults with type 2 diabetes not controlled by diet and exercise have been completed. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Onglyza (saxagliptin) (saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2011-05-11